Download the Doctor Discussion Guide PDFDOWNLOAD DISCUSSION GUIDE
Please see additional ELOCTATE Safety Data
The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.
Why is it important to consider my joints in my treatment decisions?
What are the potential benefits and risks for me and my joints in choosing a factor treatment like ELOCTATE?
How does ELOCTATE work to protect me from bleeds and resolve target joints?
How does ELOCTATE work to improve my signs of bleeding and relieve pain?
I've heard that the suggested prophylaxis starting regimen for ELOCTATE starts at 50IU/kg every 4 days and may be adjusted to every 3 or 5 days. What would that mean for me?
If I experience a breakthrough bleed after starting ELOCTATE, should I be worried? How do I treat it? When should I call the doctor's office for a follow-up?
Do you think that ELOCTATE is the right treatment for me for bleed and joint bleed protection?
Sanofi Hemophilia Community Relations and Education (CoRe) Managers offer education to people living with hemophilia and their families. CoRe Managers provide information about living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe team member nearest you.
Let's stay in touch. We'll occasionally send you important information on Hemophilia A and ELOCTATE.LET'S GET STARTED
IMPORTANT SAFETY INFORMATION AND INDICATIONS
IMPORTANT SAFETY INFORMATION
Do not use ELOCTATE if you have had an allergic reaction to it in the past.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.
Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.
If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.
These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.
Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078
CLICK HERE TO LEARN MORE ABOUT SANOFI'S COMMITMENT TO FIGHTING COUNTERFEIT DRUGS.